CNMD

CONMED Corporation

Healthcare · USD

CNMD

Price

$34.08

-2.04%

Cap

$1.1B

Earnings

4/4 beat

30d Trend

-2%

CNMD
Loading chart data...
0 data pointsPowered by Brain47
52-week range3%
33.2161.08

Near 52-week lows — potential value or falling knife

Analyst consensus (6 analysts)+30% to target
0 Strong Buy0 Buy6 Hold0 Sell0 Strong Sell

Target range: $39$52 (consensus: $44.2)

Consensus: Hold

Earnings history

Q4 2025

BEAT

1.43 vs 1.32

Q3 2025

BEAT

1.08 vs 1.05

Q2 2025

BEAT

1.15 vs 1.13

Q1 2025

BEAT

0.95 vs 0.81

VolatilityModerate

Key macro factors

·

Global Growth Slowdown & Geopolitical Uncertainty: The ongoing Middle East conflict and the IMF's anticipated downgrade of global growth forecasts could lead to reduced demand for elective procedures and constrained healthcare spending. Higher oil prices also increase operational and shipping costs, impacting profitability. [cite: 34 (previous searches)]

·

Inflationary Pressures & Supply Chain Disruptions: Elevated oil prices, influenced by geopolitical tensions, could increase CONMED's operational costs for manufacturing, transportation, and raw materials, thereby impacting profit margins. [cite: 34 (previous searches)]

·

Hospital Capital Spending & Elective Procedure Volumes: The broader economic climate directly influences hospital budgets for capital expenditures and patient willingness to undergo elective surgeries, which are key drivers for medical device sales. The US jobs report, while positive, is set against global uncertainties that may temper confidence in large-scale capital investments within healthcare.

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures.

Next earnings:2026-04-29

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

CONMED Corporation (CNMD) — Brain47 AI Score 38/100 | Analysis